lumacaftor/ivacaftor will lessen the extent or influence of abemaciclib by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug. Coadministration of abemaciclib with powerful CYP3A4 inducers decreases plasma concentration of abemaciclib and its metabolites. Hence the